CCR5-Δ32 polymorphism: a possible protective factor for post-stroke depressive symptoms

O Tene, H Hallevi, J Molad, S Usher, E Seyman… - Journal of Psychiatry and …, 2021 - jpn.ca
Background: A naturally occurring loss-of-function mutation in the gene for CC chemokine
receptor type 5 (CCR5-Δ32) has recently been reported as a protective factor in post-stroke …

Increased brain damage after ischaemic stroke in mice lacking the chemokine receptor CCR5

S Sorce, J Bonnefont, S Julien… - British journal of …, 2010 - Wiley Online Library
Background and purpose: The chemokine receptor CCR5 is well known for its function in
immune cells; however, it is also expressed in the brain, where its specific role remains to be …

Dual effect of C–C motif chemokine receptor 5 on ischemic stroke: More harm than benefit?

K Jing, F Chen, X Shi, J Guo, X Liu - European Journal of Pharmacology, 2023 - Elsevier
Ischemic stroke involves a series of complex pathological mechanisms, of which
neuroinflammation is currently the most widely recognized. C–C motif chemokine receptor 5 …

[PDF][PDF] CCR5 is a therapeutic target for recovery after stroke and traumatic brain injury

MT Joy, EB Assayag, D Shabashov-Stone… - Cell, 2019 - cell.com
We tested a newly described molecular memory system, CCR5 signaling, for its role in
recovery after stroke and traumatic brain injury (TBI). CCR5 is uniquely expressed in cortical …

Common CCR5-del32 frameshift mutation associated with serum levels of inflammatory markers and cardiovascular disease risk in the Bruneck population

AR Afzal, S Kiechl, YP Daryani, A Weerasinghe… - Stroke, 2008 - Am Heart Assoc
Background and Purpose—Atherosclerosis is a progressive inflammatory disease and can
develop in large arteries such as carotid and femoral arteries or medium-sized muscular …

[HTML][HTML] Brain-derived CCR5 contributes to neuroprotection and brain repair after experimental stroke

S Ping, X Qiu, M Kyle, LR Zhao - Aging and disease, 2021 - ncbi.nlm.nih.gov
Abstract Chemokine (CC motif) receptor 5 (CCR5) is expressed not only in the immune cells
but also in cerebral cells such as neurons, glia, and vascular cells. Stroke triggers high …

[HTML][HTML] CX3C chemokine receptor 1 deficiency modulates microglia morphology but does not affect lesion size and short-term deficits after experimental stroke

G van der Maten, V Henck, T Wieloch, K Ruscher - BMC neuroscience, 2017 - Springer
Abstract Background The fractalkine/CX 3 C chemokine receptor 1 (CX 3 CR1) pathway has
been identified to play an essential role in the chemotaxis of microglia, leukocyte trafficking …

Pharmacological blockers of CCR5 and CXCR4 improve recovery after traumatic brain injury

Y Friedman-Levi, S Liraz-Zaltsman, C Shemesh… - Experimental …, 2021 - Elsevier
CCR5 and CXCR4 are structurally related chemokine receptors that belong to the
superfamily of G-protein coupled receptors through which the HIV virus enters and infects …

Knockdown of CC chemokine receptor 5 (CCR5) is protective against cerebral ischemia and reperfusion injury

E Constanza Gomez Victoria… - Current …, 2017 - ingentaconnect.com
Background: Stroke is the second leading cause of death and a major cause of disability of
adults worldwide. Inflammatory processes are known to contribute to the pathophysiology of …

The chemokine receptor CCR5-Δ32 gene mutation is not protective against Alzheimer's disease

O Combarros, J Infante, J Llorca, N Peña… - Neuroscience …, 2004 - Elsevier
Chronic local inflammatory reaction involving reactive microglia is one of the major
pathological events in Alzheimer's disease (AD). There is growing evidence that the …